425 related articles for article (PubMed ID: 6810246)
1. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of third-generation cephalosporins.
Fass RJ
Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
Auckenthaler R; Waldvogel FA
Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
[TBL] [Abstract][Full Text] [Related]
5. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
Deforges L; Le Van Thoi J; Soussy CJ; Duval J
Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
7. [Computerized analysis of activity profiles of beta-lactams].
Pitton JS; Philippin JL; Fournier P
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):581-5. PubMed ID: 3937131
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
Downs JT; Andriole VT
Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
[TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Lang SD; Edwards DJ; Durack DT
Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
[TBL] [Abstract][Full Text] [Related]
11. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
12. [Activity of new beta-lactam antibiotics].
Cullmann W; Stieglitz M
Fortschr Med; 1982 May; 100(19):888-92. PubMed ID: 6807788
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Gavan TL; Gerlach EH; Sommers HM
Clin Ther; 1980; 3(Spec Issue):14-23. PubMed ID: 6446389
[No Abstract] [Full Text] [Related]
17. A comparative study of the in-vitro activity of cefepime and other cephalosporins.
Lim VK; Halijah MY
Malays J Pathol; 1993 Jun; 15(1):65-8. PubMed ID: 8277793
[TBL] [Abstract][Full Text] [Related]
18. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Garcia-Rodriguez JA
Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
[No Abstract] [Full Text] [Related]
19. Dynamics of resistance to cephalosporins.
Atkinson BA
Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]